Disease relevance of Consensus

• The NIH followed this up with a national Consensus Development Conference on Lowering Blood Cholesterol to Prevent Heart Disease. For the first time, the NIH now went on record advocating screening for hypercholesterolemia and urging aggressive treatment for those at high risk [1].
• Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting [2].

High impact information on Consensus

• Participants in the recently convened National Institutes of Health Consensus Development Conference on the Treatment of Panic Disorder noted this problem and recommended establishment of procedures to ensure comparability of studies [3].
• The National Institutes of Health Consensus Development Conference on Lipid Lowering has recommended that cholesterol levels be reduced to 200 mg/dl in all persons [4].
• METHODS: Two parallel, consensus development studies using a modified nominal group technique involving GPs (n=5) and consultant rheumatologists (n=4) from North Staffordshire with reference panels of GPs (n=28) and rheumatologists (n=11) from selected centres in Great Britain, respectively [5].
• The proportion of patients with URR > or = 0.65, as recommended by the Renal Physicians Association and a National Institutes of Health Consensus Development Conference Statement, increased from 43% in 1993 to 49% in 1994 and 59% in 1995 [6].
• PATIENTS: Between 1988 and 1992, 152 patients classified as having NF1 according to the criteria of the National Institutes of Health Consensus Development Conference Statement were studied [7].

Chemical compound and disease context of Consensus

• Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development [8].
• A consensus development panel established guidelines for octreotide dose titration in patients with secretory diarrhea [9].
• Glycohaemoglobin: a crucial measurement in modern diabetes management. Progress towards standardisation and improved precision of measurement. Australian Diabetes Society, the Royal College of Pathologists of Australasia and the Australasian Association of Clinical Biochemists [consensus development conference] [10].

Anatomical context of Consensus

• We conclude that the criteria proposed by the National Institute of Health Consensus Development Conference are contributory in making an accurate pre-operative pathological diagnosis of intramedullary spinal cord tumour associated with NF-1 [11].

Gene context of Consensus

• A 1991 NIH Consensus Development Conference statement provided recommendations for the management of patients with asymptomatic and minimally symptomatic primary hyperparathyroidism (primary HPT), but adherence to these guidelines has not been documented [12].
• A consensus Development Conference was held at the National Institutes of Health from September 29-October 1, 1980, to address issues concerning the role of carcinoembryonic antigen (CEA) as a marker in the management of cancer [13].
• Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise [14].
• Consensus Development Conference on the Management of Clinically Localized Prostate Cancer. Overview: historical and contemporary [15].
• Developing and evaluating complementary therapy services: Part 1. Establishing service provision through the use of evidence and consensus development [16].

Analytical, diagnostic and therapeutic context of Consensus

• NICHD Consensus Development Task Force report: predictors of intrapartum fetal distress---the role of electronic fetal monitoring [17].
• Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel [9].

References